Trial intelligence / Profile preview

Phase III trial of NBP607 influenza vaccine in healthy adults and elderly

KCT0001198Phase 3Completed

Sponsor
SK Chemicals
Start
Sep 2013
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 3 trial of SKYCellflu in influenza, sponsored by SK Chemicals. Started Sep 2013; status: completed.

02

Drugs

SKYCellflu
03

Conditions

influenza

Beyond the preview

Go deeper on KCT0001198.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0001198.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call